Phio Pharmaceuticals (PHIO) Dividends Paid - Common (2012 - 2015)
Phio Pharmaceuticals' (PHIO) quarterly Dividends Paid - Common came in at $185000.0 in Q1 2015, down 89.46% YoY from $1.8 million in Q1 2014, and down 59.96% on a QoQ basis from $462000.0 in Q4 2014.
Phio Pharmaceuticals (PHIO) Dividends Paid - Common (2012 - 2015) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 4 years of Dividends Paid - Common data on file, last reported at $185000.0 in Q1 2015.
- Quarterly Dividends Paid - Common fell 89.46% year-over-year to $185000.0 in Q1 2015, while the trailing twelve-month figure through Mar 2015 was -$5.0 million (down 328.85% YoY) and the FY2014 annual result came in at $4.1 million, up 34316.67% from the prior year.
- Dividends Paid - Common eased to $185000.0 in Q1 2015, from $462000.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $3.5 million in Q1 2013 to a low of -$7.4 million in Q4 2013.
- A 4-year average of -$85666.7 and a median of $690000.0 in 2012 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2013 — Dividends Paid - Common sank 904.03% — and 2014, when it surged 106.26%.
- Tracing PHIO's Dividends Paid - Common over 4 years: stood at $918000.0 in 2012, then slumped by 904.03% to -$7.4 million in 2013, then surged by 106.26% to $462000.0 in 2014, then tumbled by 59.96% to $185000.0 in 2015.
- The last three Dividends Paid - Common figures came in at $185000.0 (Q1 2015), $462000.0 (Q4 2014), and $1.8 million (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 185,000.00 |
| Mar 31, 2015 | 185,000.00 |
| Dec 31, 2014 | 462,000.00 |
| Dec 31, 2014 | 462,000.00 |
| Mar 31, 2014 | 1.76 Mn |
| Mar 31, 2014 | 1.76 Mn |
| Dec 31, 2013 | -7.38 Mn |
| Dec 31, 2013 | -7.38 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Dec 31, 2012 | 918,000.00 |
| Dec 31, 2012 | 918,000.00 |